Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

112.68 +1.21 (+1.09%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

53 54 Next >

Nasdaq, S&P Futures Falter As Mixed Earnings Weigh Down On Sentiment ↗

April 19, 2023

Earnings continue to be front and center in the market, with futures trading signaling a negative start on Wednesday. More bellwether names are due to turn in their quarterly scorecard, potentially...

Via Benzinga

Morgan Stanley, Tesla And 3 Stocks To Watch Heading Into Wednesday ↗

April 19, 2023

With US futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Investor Optimism Declines Following Earnings Reports ↗

April 19, 2023

The CNN Money Fear and Greed index showed some decline in overall sentiment among U.S. investors on Tuesday. U.S stocks closed mostly flat on Tuesday as investors digested the recent batch of earnings...

Via Benzinga

Major Earnings Misses And Beats: Your Guide To This Week's Big Earnings In Play ↗

April 18, 2023

We saw other large financial companies report their earnings along with stocks across other sectors miss or exceed expectations though the broader market was completely unchanged by the close.

Via Talk Markets

New York Rep. Daniel Goldman Sold Over $50K Worth of Abbott Laboratories Stock: Here's What You Should Know ↗

April 18, 2023

Via Benzinga

A Preview Of Abbott Laboratories's Earnings ↗

April 18, 2023

Via Benzinga

Abbott Laboratories, National Retail Properties, UnitedHealth Group And A Big Bank Reporting Upbeat Earnings: CNBC's 'Final Trades' ↗

April 18, 2023

On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Abbott Laboratories (NYSE: ABT)

Via Benzinga

Profit from the Artificial Intelligence Boom with These 7 AI ETFs ↗

April 17, 2023

The artificial intelligence revolution is already here, creating a massive $1.81 trillion opportunity for AI ETFs.

Via InvestorPlace

What's In Store For Abbott Laboratories In Q1 Earnings? ↗

April 15, 2023

Abbott Laboratories is slated to report first-quarter 2023 results on Apr. 19 before the market opens.

Via Talk Markets

10 Analysts Have This to Say About Abbott Laboratories ↗

April 05, 2023

Via Benzinga

Peering Into Abbott Laboratories's Recent Short Interest ↗

March 16, 2023

Via Benzinga

3 No-Brainer Medical Device Stocks to Buy Right Now ↗

April 06, 2023

These companies have consistently delivered revenue and EPS gains.

Via The Motley Fool

3 Discounted Dividend Stocks With Combined 150+ Years Of Dividend Growth ↗

April 06, 2023

All three of these dividend stocks have paid a growing dividend for more than 25 years each

Via The Motley Fool

Better Dividend Stock: AbbVie vs. Johnson & Johnson ↗

April 05, 2023

Both companies have a lot to offer income-seekers.

Via The Motley Fool

3 Dividend-Growth Stocks to Buy in April That Can Crush Inflation ↗

April 02, 2023

No need to worry about keeping up with inflation with these rapidly growing payouts.

Via The Motley Fool

3 Healthcare Stocks to Watch As the Industry Evolves ↗

March 31, 2023

Healthcare stocks are often considered a safe investment due to the consistent demand for medical products and services.

Via InvestorPlace

2 Dividend Stocks Down 11% to 22% to Buy and Hold Forever ↗

March 28, 2023

Investors should buy the dips on these healthcare giants.

Via The Motley Fool

Can Healthcare Stocks Survive Macro Headwinds? ↗

March 27, 2023

Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year.

Via Talk Markets

2 High-Yield Dividend Stocks You Won't Regret Buying Right Now ↗

March 23, 2023

These two blue-chip dividend stocks offer investors a reliable income stream in a volatile market.

Via The Motley Fool

Republicans Seek Documents, Schedule Hearing Related To FDA's Response To Baby-Formula Shortage ↗

March 21, 2023

House Republicans are reportedly speeding up their scrutiny of the FDA and the White House's handling of the baby formula shortage last year.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 16, 2023

Via Benzinga

Healthcare Stocks With at Least 30 Years of Dividend Increases

March 14, 2023

Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.

Via MarketBeat

FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities ↗

March 10, 2023

Via Benzinga

2 Top Dividend Stocks You Can Buy and Hold Forever ↗

March 09, 2023

These two companies have been growing their payouts for more than a century combined.

Via The Motley Fool

Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason ↗

March 07, 2023

Via Benzinga

Why The Apple Watch Comes Up Short In Heart Attack Detection… And Other Alternatives ↗

March 06, 2023

While there can be some value in having a single-lead ECG always available, patients with known heart conditions need much better technology.

Via Talk Markets

7 Dividend Kings to Buy for an Uncertain Market Environment ↗

March 06, 2023

With so much turbulence in the global economy, these dividend kings to buy may help you weather the extreme storm.

Via InvestorPlace

Healthcare Is Lagging But Biotech Offers Good Potential For Value And Trading ↗

March 06, 2023

Over the past week, the market had a nice uptick making it harder for defensive sectors like healthcare to get traction up only 0.51% and down almost 5% YTD.

Via Talk Markets

Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories ↗

March 06, 2023

The FDA will allow two of Abbott's CGMs to be paired with automated insulin pumps.

Via Investor's Business Daily

Abbott's MitraClip Shows Long Term Benefits In Patients With Leaky Heart Valves ↗

March 06, 2023

Via Benzinga

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

53 54 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Abbott Laboratories (NY:ABT)

All News about Abbott Laboratories

Starting at $3.75/week.

Subscribe Today